Vol. 3, Issue 1 Several years ago, a patient with HIV arrived at the infectious disease program at Grady Health System in Atlanta, Georgia, with a bottle of pills covered in soot. A nurse jokingly asked, “Where are you keeping this, the fireplace?” The patient responded, “How did you guess?” Fearing stigma and discrimination, the woman was hiding her pills in order to keep her HIV status a secret.
| Vol. 3, Issue 1 The VERxVE trial is an ongoing, multinational, Phase 3, double-blind, double-dummy, parallel-group, active-controlled trial with stratified randomization.1 It is being conducted at 175 centers in 20 countries around the world.2
|